哈莫尼生物科技

US · HRMY #2681 按市值排名上市于 2020

37.95 -0.32 -0.84%

实时 - 追踪5344个代码 - 心跳于46秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

机构持股总比例下降了0.3个百分点。

机构持股

机构持股比例: 107.90% -0.30pp
机构数量: 394
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund68.43%

Hedge Fund13.74%

Private Company13.59%

VC/PE Fund5.95%

Public Company3.69%

Government Pension Fund1.28%

Family Office/Trust0.74%

Sovereign Wealth Fund0.25%

Bank/Investment Bank0.12%

主要股东截至 2026-06-30

BlackRock 12.20% · 7.10M 股

Marshman Fund Trust II 10.39% · 6.05M 股

FMR 6.14% · 3.57M 股

Vanguard Portfolio Management, LLC 4.95% · 2.88M 股

American Century Investment Management 4.36% · 2.54M 股

Vanguard Capital Management, LLC 4.13% · 2.40M 股

Dimensional Fund Advisors 4.11% · 2.39M 股

HBM Healthcare Investments AG 3.69% · 2.15M 股

LSV Asset Management 3.54% · 2.06M 股

State Street Global Advisors 3.19% · 1.86M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 24次买入 · 23次卖出

姓名	职务	持股比例
Marshman Fund Trust II	--	10.39%
Sandip Kapadia	Executive VP, Chief Administrative Officer & CFO	0.04%
Kumar Budur	Chief Medical Officer	0.02%
Jeffrey Dayno	Chief Executive Officer	0.02%
Andrew Serafin	Chief Strategy Officer	0.01%
Adam Zaeske	EVP & Chief Commercial Officer	0.01%
Stephen Mollichella	Senior VP, Controller & Interim Principal Financial Officer	0.00%
Jeffrey Aronin	Non-Executive Chairperson	0.00%
R. Graf	Independent Director	--
Gary Sender	Independent Director	--

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-17	Kumar Budur	Chief Medical Officer	Derivative Exercise and Sale	-38,452	$30.27–43.05
2026-09-17	Kumar Budur	Chief Medical Officer	Intent to Sell (Form 144)	-35,852	$42.74
2026-09-16	Kumar Budur	Chief Medical Officer	Intent to Sell (Form 144)	-800	$42.21
2026-09-15	Kumar Budur	Chief Medical Officer	Intent to Sell (Form 144)	-1,800	$42.17
2026-09-07	Kumar Budur	Chief Medical Officer	Automatic Disposition	-11,000	$41.98–42.79
2026-09-07	Kumar Budur	Chief Medical Officer	Derivative Exercise and Sale	-22,954	$30.27–43.10
2026-09-03	Kumar Budur	Chief Medical Officer	Intent to Sell (Form 144)	-5,500	$41.86
2026-08-06	Valor Management LLC	--	Intent to Sell (Form 144)	-700,883	$37.90
2026-07-15	Stephen Mollichella	Senior VP, Controller & Interim Principal Financial Officer	Initial Statement of Beneficial	0	--
2026-07-01	Sandip Kapadia	Executive VP, Chief Administrative Officer & CFO	Intent to Sell (Form 144)	-25,000	$36.96
2026-06-29	Sandip Kapadia	Executive VP, Chief Administrative Officer & CFO	Intent to Sell (Form 144)	-50,000	$36.08
2026-06-25	Sandip Kapadia	Executive VP, Chief Administrative Officer & CFO	Intent to Sell (Form 144)	-45,594	$35.24
2026-06-23	Sandip Kapadia	Executive VP, Chief Administrative Officer & CFO	Intent to Sell (Form 144)	-4,406	$35.02
2026-06-08	Sandip Kapadia	Executive VP, Chief Administrative Officer & CFO	Intent to Sell (Form 144)	-27,960	$33.74
2026-06-04	Sandip Kapadia	Executive VP, Chief Administrative Officer & CFO	Intent to Sell (Form 144)	-2,101	$33.08
2026-06-03	Sandip Kapadia	Executive VP, Chief Administrative Officer & CFO	Intent to Sell (Form 144)	-7,064	$33.02
2026-05-13	R. Graf	Independent Director	Other Derivative Acquisition	+21,872	$30.76
2026-05-13	Gary Sender	Independent Director	Other Derivative Acquisition	+21,872	$30.76
2026-05-13	Linda Szyper	Independent Director	Other Derivative Acquisition	+21,872	$30.76
2026-05-13	Geno Germano	Independent Director	Other Derivative Acquisition	+21,231	$30.76

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。